Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
31.1M
-
Shares change
-
-571K
-
Total reported value, excl. options
-
$308M
-
Value change
-
-$7.9M
-
Put/Call ratio
-
2.67
-
Number of buys
-
46
-
Number of sells
-
-35
-
Price
-
$9.90
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2016
113 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q4 2016.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.1M shares
of 170M outstanding shares and own 18.26% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (12.7M shares), FMR LLC (6.05M shares), Capital World Investors (1.56M shares), VANGUARD GROUP INC (1.46M shares), FEDERATED INVESTORS INC /PA/ (1.11M shares), BlackRock Fund Advisors (1.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (752K shares), Artal Group S.A. (700K shares), D. E. Shaw & Co., Inc. (538K shares), and ARK Investment Management LLC (492K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.